MX2013008995A - Composicion farmaceutica para el tratamiento del dolor. - Google Patents
Composicion farmaceutica para el tratamiento del dolor.Info
- Publication number
- MX2013008995A MX2013008995A MX2013008995A MX2013008995A MX2013008995A MX 2013008995 A MX2013008995 A MX 2013008995A MX 2013008995 A MX2013008995 A MX 2013008995A MX 2013008995 A MX2013008995 A MX 2013008995A MX 2013008995 A MX2013008995 A MX 2013008995A
- Authority
- MX
- Mexico
- Prior art keywords
- inflammatory
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salts
- treating pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una combinación sinérgica con efecto analgésico, antiinflamatorio y antipirético potencializado que comprende a) al menos un antiinflamatorio no esteroideo y/o sus sales farmacéuticamente aceptables; y, b) al menos un antiinflamatorio del grupo de los salicilatos. Además, se refiere a una composición farmacéutica que comprende al menos un núcleo de liberación retardada y/o liberación inmediata que contiene al menos un antiinflamatorio no esteroideo y/o sus sales farmacéuticamente aceptables y/o al menos un antiinflamatorio del grupo de los salicilatos; y al menos dos capas de liberación inmediata y/o prolongada que contienen al menos un antiinflamatorio no esteroideo y/o sus sales farmacéuticamente aceptables y/o al menos un antiinflamatorio del grupo de los salicilatos.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2013008995A MX2013008995A (es) | 2013-08-02 | 2013-08-02 | Composicion farmaceutica para el tratamiento del dolor. |
PCT/MX2014/000115 WO2015016696A1 (es) | 2013-08-02 | 2014-07-24 | Composición farmacéutica para el tratamiento del dolor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2013008995A MX2013008995A (es) | 2013-08-02 | 2013-08-02 | Composicion farmaceutica para el tratamiento del dolor. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013008995A true MX2013008995A (es) | 2014-03-24 |
Family
ID=50935220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013008995A MX2013008995A (es) | 2013-08-02 | 2013-08-02 | Composicion farmaceutica para el tratamiento del dolor. |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX2013008995A (es) |
WO (1) | WO2015016696A1 (es) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU170329B (es) * | 1974-12-12 | 1977-05-28 | ||
US5316772A (en) * | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
US6277362B1 (en) * | 1999-10-26 | 2001-08-21 | Isw, Inc. | After shave treatment preparation |
US20040077609A1 (en) * | 2001-01-16 | 2004-04-22 | Michael Rubin | Oral composition containing NSAIDs and essential oils |
AU2007224229B2 (en) * | 2006-03-06 | 2012-10-11 | Pozen Inc. | Dosage forms for administering combinations of drugs |
US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
-
2013
- 2013-08-02 MX MX2013008995A patent/MX2013008995A/es unknown
-
2014
- 2014-07-24 WO PCT/MX2014/000115 patent/WO2015016696A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015016696A1 (es) | 2015-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY196173A (en) | Cot Modulators And Methods Of Use Thereof | |
WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
CL2018000222A1 (es) | Nueva combinación para el uso en el tratamiento del cáncer | |
IL244995B (en) | A pharmaceutical composition containing a pcsk9 inhibitor in the treatment of hyperlipidemia | |
BR112015020466A2 (pt) | inibidores de cdc7 | |
MX2022001796A (es) | Metodos y composiciones para inhibir los sintomas asociados con la veisalgia. | |
EA201491039A1 (ru) | Комбинации диацереина и нестероидных противовоспалительных лекарственных средств | |
WO2015056094A3 (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent | |
PH12015501783A1 (en) | Pharmaceutical compositions for the treatment of helicobacter pylori | |
EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
EP3322444A4 (en) | A TUMOR THERAPEUTIC AGENT COMPRISING AN IDO INHIBITOR ADMINISTERED IN ASSOCIATION WITH ANTIBODY | |
PH12016500910A1 (en) | Long-acting ketoprofen compositions | |
MX2015013151A (es) | Métodos de tratamiento de disquinesia y trastornos relacionados. | |
CL2016002655A1 (es) | Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol | |
MX2013008995A (es) | Composicion farmaceutica para el tratamiento del dolor. | |
CO7170180A2 (es) | Composición farmacéutica inyectable de dexketoprofeno y tramadol | |
IN2013MU03428A (es) | ||
EA201692426A1 (ru) | Комбинации зальтопрофена и миорелаксанта | |
WO2015004634A3 (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio | |
GT201300318A (es) | Composición farmacéutica para uso en inflamación y dolor | |
MX2014011922A (es) | Composicion para el tratamiento de desordenes inflamantorios e inmunes. | |
MX2013008993A (es) | Sistema de liberacion modificada en tres fases de un antiinflamatorio no esteroide. | |
WO2012016314A9 (pt) | Compostos derivados do ácido araquidônico substituídos com análogos de coxibes para tratamento de dor | |
MX345917B (es) | Composiciones analgesicas que comprenden quercetina mas ketorolaco. | |
MX2012000360A (es) | Combinacion de un atiinflamatorio no esteroideo y un antiespasmodico. |